Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

IMAC Holdings Launches Ignite Proteomics, Its New Subsidiary To Help Doctors Select Most Effective Cancer Treatments Based On Protein-level Insights

Author: Benzinga Newsdesk | January 27, 2025 05:12pm

This move addresses a growing need for better, faster ways to personalize therapy in breast cancer and beyond.

Posted In: BACK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist